This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mok, C. Articles by Ma, K. Search for Related Content PubMed PubMed Citation Articles by Mok, C. Articles by Ma, K. Social Bookmarking                         What's this?

Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus

Department of Medicine, Tuen Mun Hospital, Hong Kong, SAR China ccmok2005{at}yahoo.com

CH To

Department of Medicine, Tuen Mun Hospital, Hong Kong, SAR China

KM Ma

Department of Nuclear Medicine, Tuen Mun Hospital, Hong Kong, SAR China

The aim of this study was to evaluate the changes in body composition after glucocorticoid treatment in patients with systemic lupus erythematosus (SLE). Consecutive SLE patients were recruited for serial measurements (baseline, months 2 and 6) of bone mineral density (BMD) and body composition [bone mineral content (BMC), fat and lean mass] by dual energy X-ray absorptiometry scan after high-dose oral glucocorticoid therapy. Factors correlated with changes in body composition were evaluated. 29 SLE patients were studied (age 39.7 ± 11.5 years; 83% women with 29% postmenopausal; SLE duration 80.1 ± 80 months). Fourteen patients (48%) were glucocorticoid-naive. The mean maximum daily dosage of prednisolone was 32.9 ± 6.5 mg and the cumulative prednisolone dosage in 6 months was 2.7 ± 0.7 g. At 6 months, a significant drop in BMC of the trunk (–5.0 ± 2.2%; P = 0.04) and whole body (–1.2 ± 0.4%; P = 0.002) compared with baseline was observed, and so was the BMD of the hip (–1.7 ± 0.6%; P = 0.006) and whole body (–0.7 ± 0.3%; P = 0.01). A significant increase in the fat mass of the trunk (+14.5 ± 4.1%; P = 0.001) and limbs (+10.0 ± 3.2%; P = 0.004), but a non-significant drop in lean mass of the trunk (–3.3 ± 1.8%; P = 0.08) and limbs (–0.8 ± 2.4%; P = 0.75) also occurred. The changes in whole body BMC correlated significantly with age ( = –0.51; P = 0.02) and changes in total fat mass ( = 0.44; P = 0.02) but not with lean mass ( = –0.21; P = 0.27), gender, body mass index, smoking, prednisolone dosages or changes in BMD. In SLE patients, high-dose glucocorticoids lead to an early and rapid drop in bone mass, which is more serious in older patients and correlates with an increase in body fat.

Key Words: bone mineral density • fat mass • lean mass • osteoporosis • prednisolone

Lupus, Vol. 17, No. 11, 1018-1022 (2008)
DOI: 10.1177/0961203308093552


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?